Retatrutide

Description

Also known as: LY3437943

CAS Number: 2381089-83-2
Molecular Formula: C187H291N51O60
Molecular Weight: Approx. 4260 g/mol
Form: Lyophilized Powder
Quantity: 6 mg to 24 mg
Purity: 98 percent or higher (HPLC Verified)

Product Overview

This investigational peptide is a triple receptor agonist that engages GLP1, GIP, and glucagon pathways. Current research focuses on how this combined activity may support metabolic function, weight regulation, and insulin response. Early findings suggest that multi receptor models can offer more insight than single or dual targeting approaches. Research interest includes:

Weight and metabolic regulation models Glucose control and Type 2 diabetes studies Lipid metabolism and energy balance research Development of multi hormonal metabolic therapy concepts

Applications in Research

GLP1, GIP, and glucagon synergy studies Body composition and energy use investigations Glycemic control and insulin response analysis Preclinical evaluation of next generation incretin based compounds

Clinical Data: GLP-3RT: Triple–Hormone-Receptor Agonist for Obesity — A Phase 2 Trial GLP-3RT: A Study (LY3437943) in Participants With Obesity and Cardiovascular Disease (TRIUMPH-3) GLP-3RT: Triple-Hormone-Receptor Agonist Study for Obesity – A Phase 2 Trial

Storage and Handling

Store the lyophilized material at minus 20 degrees Celsius in a dark and dry location. Reconstitute with bacteriostatic water using sterile technique. After reconstitution, refrigerate at 2 to 8 degrees Celsius and use within standard research timelines. Limit freeze thaw cycles.

Research Use Only – Legal Disclaimer

All Eagle Peptides products labeled as Research Use Only (RUO) are intended strictly for laboratory, investigational, and scientific research purposes. These materials are not approved by the FDA and are not intended for human or veterinary use, clinical applications, diagnostic procedures, or therapeutic treatment of any kind. By purchasing or using RUO materials, you acknowledge that they will be handled only within an appropriate research environment by qualified personnel who understand the risks, limitations, and regulatory requirements associated with experimental compounds. Products must not be administered to humans or animals, offered as therapeutic agents, or represented as safe or effective for any medical purpose. Use of these materials is entirely at your own risk. Eagle Peptides assumes no liability for misuse, unsafe handling, improper application, or any regulatory or compliance issues arising from their use.